BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 17851870)

  • 1. LRIG1 expression in colorectal cancer.
    Ljuslinder I; Golovleva I; Palmqvist R; Oberg A; Stenling R; Jonsson Y; Hedman H; Henriksson R; Malmer B
    Acta Oncol; 2007; 46(8):1118-22. PubMed ID: 17851870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased copy number at 3p14 in breast cancer.
    Ljuslinder I; Malmer B; Golovleva I; Thomasson M; Grankvist K; Höckenström T; Emdin S; Jonsson Y; Hedman H; Henriksson R
    Breast Cancer Res; 2005; 7(5):R719-27. PubMed ID: 16168117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity.
    Goldoni S; Iozzo RA; Kay P; Campbell S; McQuillan A; Agnew C; Zhu JX; Keene DR; Reed CC; Iozzo RV
    Oncogene; 2007 Jan; 26(3):368-81. PubMed ID: 16847455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor (EGF) A61G polymorphism and EGF gene expression in normal colon tissue from patients with colorectal cancer.
    Spindler KL; Nielsen JN; Ornskov D; Brandslund I; Jakobsen A
    Acta Oncol; 2007; 46(8):1113-7. PubMed ID: 17851837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors.
    Guo D; Nilsson J; Haapasalo H; Raheem O; Bergenheim T; Hedman H; Henriksson R
    Acta Neuropathol; 2006 Mar; 111(3):238-46. PubMed ID: 16532360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paracrine regulation of growth factor signaling by shed leucine-rich repeats and immunoglobulin-like domains 1.
    Yi W; Holmlund C; Nilsson J; Inui S; Lei T; Itami S; Henriksson R; Hedman H
    Exp Cell Res; 2011 Feb; 317(4):504-12. PubMed ID: 21087604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte antigen-E protein is overexpressed in primary human colorectal cancer.
    Levy EM; Bianchini M; Von Euw EM; Barrio MM; Bravo AI; Furman D; Domenichini E; Macagno C; Pinsky V; Zucchini C; Valvassori L; Mordoh J
    Int J Oncol; 2008 Mar; 32(3):633-41. PubMed ID: 18292941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of the type III epidermal growth factor receptor mutation in colorectal cancer.
    Spindler KL; Olsen DA; Nielsen JN; Brandslund I; Poulsen HS; Villingshøj M; Jakobsen A
    Anticancer Res; 2006; 26(6C):4889-93. PubMed ID: 17214357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
    Schlomm T; Kirstein P; Iwers L; Daniel B; Steuber T; Walz J; Chun FH; Haese A; Kollermann J; Graefen M; Huland H; Sauter G; Simon R; Erbersdobler A
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6579-84. PubMed ID: 18006757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
    Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients.
    Perathoner A; Pirkebner D; Brandacher G; Spizzo G; Stadlmann S; Obrist P; Margreiter R; Amberger A
    Clin Cancer Res; 2005 May; 11(9):3274-9. PubMed ID: 15867223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Color multiplex polymerase chain reaction for quantitative analysis of epidermal growth factor receptor genes in colorectal adenocarcinoma.
    Layfield LJ; Bernard PS; Goldstein NS
    J Surg Oncol; 2003 Aug; 83(4):227-31. PubMed ID: 12884235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ErbB 1-4 expression alterations in primary colorectal cancers and their corresponding metastases.
    Ljuslinder I; Malmer B; Isaksson-Mettävainio M; Oberg A; Henriksson R; Stenling R; Palmqvist R
    Anticancer Res; 2009 May; 29(5):1489-94. PubMed ID: 19443355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coexpression of the IGF-IR, EGFR and HER-2 is common in colorectal cancer patients.
    Cunningham MP; Essapen S; Thomas H; Green M; Lovell DP; Topham C; Marks C; Modjtahedi H
    Int J Oncol; 2006 Feb; 28(2):329-35. PubMed ID: 16391786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of BMP7 in human colorectal cancer.
    Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
    Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor receptor analyses in colorectal cancer: a comparison of methods.
    Spindler KL; Lindebjerg J; Nielsen JN; Olsen DA; Bisgård C; Brandslund I; Jakobsen A
    Int J Oncol; 2006 Nov; 29(5):1159-65. PubMed ID: 17016647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological significance of the gene expression of matrix metalloproteinase-7, insulin-like growth factor-1, insulin-like growth factor-2 and insulin-like growth factor-1 receptor in patients with colorectal cancer: insulin-like growth factor-1 receptor gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Yamada R; Fujii S; Rino Y; Kunisaki C; Tanaka K; Masuda M; Imada T
    Oncol Rep; 2008 Aug; 20(2):359-64. PubMed ID: 18636198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression.
    Gustafsson A; Hansson E; Kressner U; Nordgren S; Andersson M; Lönnroth C; Lundholm K
    Acta Oncol; 2007; 46(8):1107-12. PubMed ID: 17943472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Alteration of early growth response 1 expression in gastroenterological cancers and its biological significance].
    An J; Guo RF; Zhang L; Geng PL; Lü YY
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(20):1384-9. PubMed ID: 18953875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.